Evaluating the cost-effectiveness of HIV testing in emergency departments across the U.S.
Cost-Effectiveness of HIV Testing in U.S. Emergency Departments
This study is looking at how emergency rooms can make it easier for people to get tested for HIV, especially since many don’t get tested there right now, and it aims to find out what’s stopping people from getting tested, so we can help more folks know their status and get the care they need.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11009193 on NIH RePORTER |
What this research studies
This research investigates how emergency departments (EDs) can effectively increase HIV testing rates, which are currently low compared to other healthcare settings. It aims to identify barriers to testing, such as cost concerns and the impact on ED overcrowding, especially in the context of the COVID-19 pandemic. By analyzing the cost-effectiveness of HIV screening in targeted geographic areas, the research seeks to provide insights that could lead to improved testing practices and ultimately help reduce the number of undiagnosed HIV cases in the U.S.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who visit emergency departments and may be at risk for HIV but have not been tested.
Not a fit: Patients who are already diagnosed with HIV or those who do not visit emergency departments will not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to increased HIV testing rates in emergency departments, resulting in earlier diagnosis and treatment for patients.
How similar studies have performed: Previous research has shown that increasing HIV testing in emergency departments can lead to better health outcomes, indicating that this approach has potential for success.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Bennett, Christopher L — Stanford University
- Study coordinator: Bennett, Christopher L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.